Lianjun Xing
Impact in
-
- Liver physiology and pathology
- Pharmacology top 10%
- Berberine and alkaloids research
Papers in
- Epidemiology 11
- Liver Disease Diagnosis and Treatment 10
-
- Peroxisome Proliferator-Activated Receptors 4
- Phenothiazines and Benzothiazines Synthesis and Activities 1
- Co-authors
- Guang Ji (10 shared papers)Peiyong Zheng (10 shared papers)Li Zhang (5 shared papers)Tao Liu (4 shared papers)Yongqiang Hua (1 shared paper)Tao Wu (4 shared papers)Mingyuan Wu (1 shared paper)Lili Yang (2 shared papers)
In The Last Decade
Lianjun Xing
22 papers receiving 365 citations
Peers
Comparison fields: 5 of 57
- Hepatology 39
- Pharmacology 38
- Pharmacology 69
- Epidemiology 124
- Endocrinology, Diabetes and Metabolism 59
Countries citing papers authored by Lianjun Xing
This map shows the geographic impact of Lianjun Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianjun Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianjun Xing more than expected).
Fields of papers citing papers by Lianjun Xing
This network shows the impact of papers produced by Lianjun Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianjun Xing. The network helps show where Lianjun Xing may publish in the future.
Co-authors
The 25 scholars most cited alongside Lianjun Xing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 75 | |
| 2 | Hawthorn leaf flavonoids alleviate nonalcoholic fatty liver disease by enhancing the adiponectin/AMPK pathway. | 2015 | 43 |
| 3 | 2022 | 39 | |
| 4 | 2013 | 35 | |
| 5 | 2016 | 28 | |
| 6 | 2020 | 26 | |
| 7 | 2018 | 21 | |
| 8 | 2024 | 18 | |
| 9 | 2013 | 14 | |
| 10 | 2023 | 14 | |
| 11 | 2021 | 14 | |
| 12 | 2014 | 12 | |
| 13 | 2021 | 7 | |
| 14 | 2014 | 6 | |
| 15 | 2021 | 6 | |
| 16 | [Regulatory effects of Qinggan Huoxue Recipe on matrix metalloproteinases of alcoholic liver fibrosis rats]. | 2011 | 3 |
| 17 | 2009 | 3 | |
| 18 | 2021 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2023 | 1 |
About Lianjun Xing
Lianjun Xing is a scholar working on Epidemiology, Molecular Biology, Surgery, Cardiology and Cardiovascular Medicine and Hepatology, having authored 25 papers that have together received 370 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (10 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Lipid metabolism and disorders (3 papers), Liver physiology and pathology (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Cholesterol and Lipid Metabolism (2 papers), Phenothiazines and Benzothiazines Synthesis and Activities (1 paper) and Liver Diseases and Immunity (1 paper). The work is most often cited by research in Hepatology (39 citations), Pharmacology (38 citations), Pharmacology (69 citations), Epidemiology (124 citations) and Endocrinology, Diabetes and Metabolism (59 citations). Lianjun Xing has collaborated with scholars based in China and France. Frequent co-authors include Guang Ji, Peiyong Zheng, Li Zhang, Tao Liu, Yongqiang Hua, Tao Wu, Mingyuan Wu, Lili Yang, Yanqi Dang and Wenjun Zhou. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Cancer Biotherapy and Radiopharmaceuticals, Pharmaceutical Biology, Annals of Palliative Medicine and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.